[1]
Shukla, N.; Siva, N.; Malik, B.; Suravajhala, P. Current challenges and implications of proteogenomic approaches in prostate cancer. Curr. Top. Med. Chem., 2020, 20(22), 1968-1980.
[2]
Bhagat, M.; Kumar, A.; Suravajhala, R. Cedrus deodara (Bark) essential oil induces apoptosis in human colon cancer cells by inhibiting nuclear factor kappa B. Curr. Top. Med. Chem., 2020, 20(22), 1981-1992.
Current Topics in Medicinal Chemistry
Title:Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy – Part-4
Volume: 20 Issue: 22
Author(s): Suman S. Thakur
Affiliation:
Export Options
About this article
Cite this article as:
Thakur S. Suman , Anti-Cancer Drug Discovery: Structure, Function and Novel Strategy – Part-4, Current Topics in Medicinal Chemistry 2020; 20 (22) . https://dx.doi.org/10.2174/156802662022200917110723
DOI https://dx.doi.org/10.2174/156802662022200917110723 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |
23
4
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Long-circulating Targeted Nanoparticles for Cancer Therapy
Current Nanoscience Histone Deacetylase Inhibitors in Cancer Therapy: New Compounds and Clinical Update of Benzamide-Type Agents
Current Topics in Medicinal Chemistry Tumour Targeting with Systemically Administered Bacteria
Current Gene Therapy Exploring Protein-Protein and Protein-Ligand Interactions in the Immune System using Molecular Dynamics and Continuum Electrostatics
Current Physical Chemistry Optimizing Target Selection and Development Strategy in Cancer Treatment; The Next Wave
Current Medicinal Chemistry - Anti-Cancer Agents mTOR, a Potential Target to Treat Autism Spectrum Disorder
CNS & Neurological Disorders - Drug Targets An HHV-8 Positive HIV Negative Multicentric Castleman’s Disease, who Responded well to Rituximab Alone
Cardiovascular & Hematological Disorders-Drug Targets The Role of Immune and Inflammatory Mechanisms in ALS
Current Molecular Medicine Neurotransmitters and Chemokines Regulate Tumor Cell Migration: Potential for a New Pharmacological Approach to Inhibit Invasion and Metastasis Development
Current Pharmaceutical Design Development of Lymphatic Vessels: Tumour Lymphangiogenesis and Lymphatic Invasion
Current Medicinal Chemistry Design and Development of Molecular Imaging Probes
Current Topics in Medicinal Chemistry Caveolin-1: A Promising Therapeutic Target for Diverse Diseases
Current Molecular Pharmacology Biosafety of Herpesvirus Vectors
Current Gene Therapy Therapeutic Effects of Progesterone in Animal Models of Neurological Disorders
CNS & Neurological Disorders - Drug Targets The Role of Major Histocompatibility Complex Polymorphisms in the Incidence and Outcome of Non-Hodgkin Lymphoma
Current Immunology Reviews (Discontinued) Pentraxins and Atherosclerosis: The Role of PTX3
Current Pharmaceutical Design Review on Patents for Ubiquitin-Proteasome Inhibitor as Medical Advance in Major Human Diseases
Recent Patents on Biomedical Engineering (Discontinued) Type I Interferons: Ancient Peptides with Still Under-Discovered Anti-Cancer Properties
Protein & Peptide Letters Targeted Therapies in Lung Cancers: Current Landscape and Future Prospects
Recent Patents on Anti-Cancer Drug Discovery Polysulfated/Sulfonated Compounds for the Development of Drugs at the Crossroad of Viral Infection and Oncogenesis
Current Pharmaceutical Design